Cystic fibrosis-related diabetes testing in Sedico

Find health labs to test for Cystic fibrosis-related diabetes in Sedico and compare all offers by prices and services.

Tests that cover Cystic fibrosis-related diabetes

Diabetes Test
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€35.00

€33.25 with our promocode

See Details

Hemoglobin Test by Polismedica

Via Rosa 18, 33078 San Vito al Tagliamento Pordenone, Italy

38.8 km

Verified

See Details

Hemoglobin Test by Casa della Salute

Via Cesare Battisti, 99, 38042 Baselga di Pinè TN, Italia

40.9 km

Unverified

See Details

Hemoglobin Test by Synlab

Via Antonio Zanchi, 89, 35133 Padova PD, Italia

49.8 km

Unverified

See Details

Hemoglobin Test by Synlab

Via Giovanni Boccaccio, 106, 35128 Padova PD, Italia

49.8 km

Unverified

See Details

Hemoglobin Test by Synlab Euganea Medica

Via Cristoforo Colombo, 13, 35020 Albignasego PD, Italia

54 km

Unverified

See Details

Diabetes Test by Policlinico Città di Udine - Polo 2

Viale Venezia, 410, 33100 Udine UD, Italia

54.6 km

Unverified

See Details

Diabetes Test by Synlab

Campo Guglielmo Marconi, 24, 30015 Chioggia VE, Italia

62.2 km

Unverified

See Details

Diabetes Test by Synlab

Via Sorte, 48, 37047 San Bonifacio VR, Italia

63.5 km

Unverified

See Details

Hemoglobin Test by CORMEDICA SRL

Via Filanda 2, 34071 Cormons Gorizia, Italy

66.8 km

Verified

See Details

Diabetes Test by Casa di Cura Salus

Corso Giuseppe Verdi, 12, 34170 Gorizia GO, Italia

74.1 km

Unverified

A Diabetes Test costs €33.00

See Details

Cystic fibrosis-related diabetes - symptoms and how to test

Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.